The disease model: implications for clinical practice Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018 Year: 2018
Applications of clinical exercise testing: different formats, different prognostic outcomes Source: International Congress 2014 – PG07 Cardiopulmonary exercise testing Year: 2014
Applications of clinical exercise testing: different formats, different prognostic outcomes Source: Annual Congress 2013 –PG14 Cardiopulmonary exercise testing in the evaluation of patients with respiratory diseases Year: 2013
A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008
Patient-ventilator interaction: assessment and clinical relevance Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020
The way forward: how to link real-life situations and clinical trial results Source: Annual Congress 2013 - Lunchtime Session "Tiotropium soft mist inhaler and mortality in COPD: results of the TIOSPIR clinical trial" Year: 2013
Reference values for adults: clinical application and limitations Source: Annual Congress 2005 - Lung function measurements and predicted values from infants to 100-year-old adults Year: 2005
Translating trials to clinical practice: results ²more real than real life itself²¹ Source: Annual Congress 2007 - Smoking cessation Year: 2007
COVID-19 and obesity: specific clinical and laboratory features Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021
The forced oscillation technique in clinical practice: methodology, recommendations and future developments Source: Guideline 2003 Year: 2003
Clinical asthma phenotypes in the real world: opportunities and challenges Source: Breathe 2015; 11:186-193 Year: 2015
What requirements should a biomarker meet to be used in the clinical and epidemiological setting? Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies Year: 2008
Adding biological markers to COPD categorisation schemes: a way towards more personalised care? Source: Eur Respir J 2016; 47:1601-1605 Year: 2016
High-flow therapy: physiological effects and clinical applications Source: Breathe, 16 (4) 200224; 10.1183/20734735.0224-2020 Year: 2020
At the interface: the translational science supporting the clinical use of anti-cytokine therapy Source: International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost? Year: 2018
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response Source: Eur Respir Rev 2014; 23: 367-378 Year: 2014
Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014
Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers Source: Eur Respir J, 55 (5) 2001028; 10.1183/13993003.01028-2020 Year: 2020
The challenges of coupling new diagnostics and treatment capacity at country level Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management Year: 2013